La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Dynavax Technologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Dynavax Technologies..

Dynavax Technologies (NASDAQ:DVAX) Azioni, Catena delle Opzioni

DYNAVAX TECHNOLOGIES CORP

Dynavax Technologies

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies Corp

Press Releases

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

News

Dynavax Comments on Glass Lewis Recommendation

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Earnings

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

DVAX

Ardelyx

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Bicara Therapeutics

CureVac

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Immunome

Immatics

MiMedx Group

Nanobiotix

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Oruka Therapeutics

Precigen

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prime Medicine

Relay Therapeutics

Sana Biotechnology

Sionna Therapeutics

ARS Pharmaceuticals

Spyre Therapeutics

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Upstream Bio

Zenas BioPharma

Zymeworks

JMP Securities

Goldman Sachs

Citizens Capital Markets

HC Wainwright & Co.

Comments

Dynavax Technologies

Dynavax Technologies (DVAX) Opzioni

Dynavax Technologies (NASDAQ:DVAX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO